Only one in 20 people eligible for tuberculosis screening attended appointments across parts of Nottingham and Nottinghamshire over a three-year period, according to a new public health report.
The Tuberculosis Joint Strategic Needs Assessment (JSNA), which will be considered by Nottingham City Council’s Health and Wellbeing Board on 25 November, identifies significant gaps in screening and early diagnosis, despite generally good treatment outcomes for people diagnosed with the disease.
Between July 2023 and May 2026, 14,231 people were identified as eligible for screening for latent tuberculosis infection (LTBI) in the Nottingham University Hospitals NHS Trust (NUH) catchment area, but only 740 attended appointments – a rate of 5.2%.
Of those screened, 146 people, or 19.7%, tested positive for latent TB, an infection which causes no symptoms and cannot be passed to others but can develop into active tuberculosis.
The report estimates that almost 900 people with latent TB could be going undetected each year, based on the proportion of positive tests among those who attended screening.
However, this estimate assumes that the same proportion of infection exists among those who did not attend.
The screening figures cover Nottingham city, Gedling, Broxtowe and parts of Rushcliffe, rather than the whole of Nottinghamshire. Comparable information was not available for other NHS providers.
The assessment highlights differences in recorded tuberculosis rates between Nottingham city and the wider county.
Between 2022 and 2024, Nottingham recorded 12.7 cases per 100,000 residents, compared with the England average of 8.5. Nottinghamshire’s rate was considerably lower, at 3.2 cases per 100,000.
Nationally, tuberculosis cases increased by 13.6% between 2023 and 2024, from 4,831 to 5,490, with the incidence rate reaching 9.4 cases per 100,000.
The report says this brings England close to the World Health Organisation’s threshold of 10 cases per 100,000, above which a country is no longer classified as having low tuberculosis incidence.
Tuberculosis is a bacterial infection which most commonly affects the lungs, although it can affect other parts of the body.
Symptoms of active TB can include a persistent cough lasting more than three weeks, fever, night sweats, unexplained weight loss and extreme tiredness.
Latent TB differs from active disease because the bacteria remain dormant in the body. Screening involves a blood test, and preventive antibiotic treatment can reduce the risk of the infection becoming active.
The national screening programme primarily targets people aged 16 to 35 who have arrived in the UK within the previous five years from countries where tuberculosis is more common.
The assessment says approximately three-quarters of active TB cases in England result from the reactivation of latent infections acquired overseas.
Of the 146 people who tested positive through the NUH screening programme, 51 had completed treatment and four had started treatment at the point covered by the analysis.
A further 43 were awaiting or had been offered an appointment, 15 had declined treatment and ten had been discharged following non-attendance.
Treatment could not be started for eight people because of pregnancy, but their subsequent outcomes could not be established from the records.
The report also identifies concerns about the time taken to diagnose active tuberculosis.
Fewer than half of patients with pulmonary TB began treatment within two months of developing symptoms.
In Nottingham, the proportion was 44.4%, while in Nottinghamshire it was 38.5%, compared with 40.9% nationally.
Between 2020/21 and 2024/25, tuberculosis accounted for 213 hospital admission episodes among Nottingham and Nottinghamshire residents, resulting in 842 hospital bed days.
Of the 95 admission episodes involving Nottingham city residents, 54 were emergencies, representing 57%.
In Nottinghamshire, 46 of 118 admission episodes were emergencies, equivalent to 39%.
The assessment suggests that some patients are reaching hospital with more advanced disease because symptoms can initially be mistaken for other conditions.
Fewer than 40 deaths with tuberculosis recorded as the underlying cause were registered across Nottingham and Nottinghamshire between 2016 and 2025. Fewer than five were laboratory-confirmed or tissue-confirmed TB deaths.
Despite these concerns, treatment outcomes for diagnosed patients were generally positive.
In 2023, 85.3% of patients with drug-sensitive TB in Nottingham completed treatment within 12 months, compared with 86.4% in Nottinghamshire and 84.4% nationally.
The assessment also identifies problems with the way screening services are funded and organised.
Within the NUH catchment area, latent TB screening is primarily delivered through a weekly clinic at the Mary Potter Health Centre, with approximately 60 appointment slots available each week, including initial and follow-up appointments.
Funding is linked to screening activity and reimbursed retrospectively, meaning that low attendance can reduce the money available for additional staff, outreach and service development.
The report warns that increasing public awareness and encouraging more people to attend could create additional demand that existing services may struggle to accommodate without increased capacity.
National shortages of tuberculosis medication have also affected services, with some appointments prioritised for patients awaiting particular medical treatments and close contacts of people with active TB.
Stakeholders reported waiting times of approximately three months for some latent TB treatment.
The assessment identifies a separate gap in Bassetlaw, where there is no dedicated latent TB screening clinic and the area does not routinely receive the new-entrant information used to identify people eligible for screening.
Instead, screening is mainly undertaken through contact tracing and when patients are identified through other healthcare routes.
This means some eligible people arriving in the area may not be identified.
Community engagement undertaken for the assessment identified poor awareness of tuberculosis, uncertainty about eligibility for free NHS treatment, stigma and practical difficulties attending appointments.
Some participants reported problems receiving appointment letters because of changes of address, temporary accommodation or shared mailboxes.
Others highlighted travel costs, employment commitments, caring responsibilities and difficulty accessing healthcare.
The report recommends greater use of text messages and telephone reminders, multilingual information, community-based testing and closer working with voluntary organisations and faith groups.
It also highlights the importance of support for people experiencing homelessness, substance misuse, imprisonment and other forms of social disadvantage.
In Nottingham and Nottinghamshire, accommodation and related support for people with TB who have no recourse to public funds is already jointly funded by local authority public health teams and the NHS integrated care board.
The assessment says stable accommodation can be essential for patients completing lengthy treatment and reducing the risk of further transmission.
There were more positive findings for childhood vaccination.
Between January 2023 and December 2025, 5,928 of 6,858 infants eligible for BCG vaccination in the NUH catchment area received the vaccine, representing 86.4%.
Of those eligible, 4,357 children, or 63.5%, were vaccinated within the recommended 28 days of birth.
However, the report identifies gaps in the information available to public health teams, including incomplete ethnicity, postcode and treatment outcome records.
It recommends establishing a shared Nottingham and Nottinghamshire tuberculosis dataset to improve monitoring across NHS providers.
Four main priorities have been proposed: increasing preventive screening and treatment, identifying active TB earlier, improving support for vulnerable groups and strengthening information sharing between services.
The Nottingham and Nottinghamshire TB Steering Group has endorsed the recommendations.
Nottingham City Council’s Health and Wellbeing Board will be asked to endorse the assessment and agree to its publication at its meeting on 25 November.
An action plan will subsequently be developed to determine how the recommendations should be implemented.


